Table 3.
Ordinal regression analysis of the influence of clinical phenodata on favorable functional status (0–2 at mRS) at discharge and on the 90th day after the stroke.
| Coefficents | OR | 95% CI | P-value |
|---|---|---|---|
| At discharge | |||
| DM | 0.496 | (0.301–0.795) | 0.005 |
| mTICI 2b–3 | 1.145 | (1.080–1.223) | < 0.001 |
| ICH | 0.503 | (0.272–0.881) | 0.021 |
| Time from symptoms to MT | 0.997 | (0.994–0.999) | 0.004 |
| MT time | 0.993 | (0.987–0.998) | 0.011 |
| at 90 day | |||
| mTICI 2b–3 | 1.095 | (1.053–1.140) | < 0.001 |
| DH | 0.298 | (0.109–0.689) | 0.009 |
Multivariate analysis. Only statistically significant results.
mRS modified Rankin Scale, OR odds ratio, CI confidence interval, DM diabetes mellitus, mTICI 2b–3 modified Thrombolysis In Cerebral Infarction 2b–3, ICH intracranial haemorrhage, MT mechanical thrombectomy, DH decompressive heamicraniectomy.